|
參考文獻 1.林弦音(1996),「縱貫性探討糖尿病及其相關慢性併發症知長期醫療資源利用」,康科學院醫務管理學研究所。 2.郭俊宏(1996),「糖尿病患者醫療資源利用情形及其相關因素之探討」,中台科技 大學醫護管理研究所 。 3.陳雁玲(1998),《一般醫學訓練手冊—內科》 4.American Diabetes Association (2008)”Economic costs of diabetes in the U.S. in 2007,”Diabetes Care, Vol.31, no.3, 596-615. 5.Adams,T.D. Gress, R.E. Smith, S.C. (2007)”Long term mortality after gastric bypass surgery”The New England Journal of medicine Vol.357, 753-761. 6.Anselmino, M. Bammer, T. Fernandez Cebrian, J.M. Daoud, F. Romagnoli, G. Torres, A. (2009)”Cost-effectiveness and budget impact of obesity surgery in patients with type 2 diabetes in three European countries”Obes. Surgery Vol.19, 1542-1549. 7.Buchwald, H. Avidor, Y. Braunwald, E. et al. (2004)”Bariatric surgery: a systematic review and meta-analysis,”Journal of the American Medical Association, Vol.292, no.14, 1724-1737. 8.Chang ,C.H. Shau,W.Y. Jiang,Y.D. Li,H.Y. Chang,T.J. Sheu,W.H. Kwok,C.F. Ho,L.T. Chuang,L.M. (2010)”Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999-2004:a national health insurance data set study”Diabet Med Vol.27, 636-643. 9.Chang, C. Lu, F. Yang,Y.C. Wu,J.S. Wu,T.J. Chen,M.S. Chuang,M.L. Tai,T.Y. (2000)”Epidemiologic study of type 2 diabetes in Taiwan”Diabetes Res Clin Pract Vol.50, Suppl. 2, S49-S59. 10.Chang, K. (2010),”Comorbidities, quality of life and patients’ willingness to pay for a cure for type 2 diabetes in Taiwan,”Public Health Vol.124.284-294. 11.Chang,S.C. Lai, M.S. Syu, C.Y. (2005)”Relationships between morbidity and mortality in diabetes and socioeconomic conditions in Taiwan”The Journal of Health Science Vol.7, 140-148. 12.Conget,D.I. Serrano,C.D. Rodriguez,J.M. Levy,M.I. Roze, S. (2006)”Cost-utility analysis of insulin pumps compared to multiple daily doses of insulin in patients with type 1 diabetes mellitus in Spain”Rev Esp Salud Publica Vol.80, 679-695. 13.Cheng,H.M. Win,M.J. Chou,H.L. Lee,W.Y. Tsai,C.Y. (2005)”Analysis of diabetic inpatient care by using NHI claims”J Intern Med Taiwan Vol.16,121-128. 14.Clarke ,P. Kelman,C. Colagiuri,S. (2006)”Factors influencing the cost of hospital care for people with diabetes in Australia” J Diabetes Complications Vol.20, 349-355. 15.Cohen, R. Pinheiro, J.S. Correa,J.I. Schiavon, C.A. (2006)oscopic Roux-en-Y gastric bypass for BMI<35kg/m2:a tailored approach”Surgery for obesity and related diseases Vol.2,401-404. 16.Durden,E.D. Alemayehu,B. Bouchard,J.R. Chu,B.C. Aarean, M. (2009),”Direct health care costs of patients with type 2 diabetes within a privately insured employed population,2000 and 2005”J Occup Enviorn Med Vol 51, 1460-1465. 17.Dixon, J.B. O’ Brien, P.E. Playfair, J. (2008)”Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial”Journal of the American Medical Association Vol.299, 316-323. 18.Dieren, S. J .Beulens, W. Schouw,Y.T. Grobbee,D.E. Neal,B. (2010)”The global burden of diabetes and it’s complication :an emerging pandemic”Eur J Cardiovasc Prev Rehabil Vol.17, Suppl 1:S3-S8. 19.Ferchak,C.V. Meneghini, L.F. (2004)”Obesity, bariatric surgery and type 2 diabetes—a systematic review,”Diabetes Metab Res Rev Vol.20, 438-445. 20.Fried, M. (2010)”Metabolic surgery”Vnitr Lek Vol.56 (10), 1065-1068. 21.Fried, M. Ribaric, G. Buchwald,J.N. Svacina,S. Dolezalova,K. Scopinaro,N. (2010)”Metabolic surgery for the treatment of type 2 diabetes in patients with BMI<35kg/m2:An integrative review of early studies”Obes Surg Vol.20,776-790. 22.Fowler,M.J. (2010)”Diabetes: Magnitude and Mechanism”Clinical Diabetes Vol.28 42-46. 23.Ginter, E. Simko, V. (2010)”Diabetes type 2 pandemic in 21st century”Bratisl Lek Listy Vol.111 (3), 134-137. 24.Huang,C.K. Asim ,S. Lo, C.H, Chen, Y.S. Houng,J.Y. (2011) ”Laparoscopic Roux-en-Y Bypass for the treatment of Type II Diabetes Mellitus in Chinese Patient with Body Mass Index of 25-35,”Springerlink.Com. 25.Huang,C.K. Houng, J.Y. Chiang, C.J. Chen, Y.S. Lee, P.H. (2009)”Single incision transumbilical laparoscopic Roux-en-Y gastric bypass: A first case report,”Obes Surgery Vol.19, 1711-1715. 26.Hawaiian, G. M. Fobi, A.L. (2004),”Surgical treatment of obesity: A review”Journal of the National Medical Association Vol.96, 61-75. 27.Hokkam, EN. (2009),”Assessment of risk factors in diabetic foot ulceration and their impact on the outcome of the disease”Prim Care Diabetes Vol.3,291-224. 28.Hamza, N. Abbas, M. Darwish, H. Shafeek, A. Z. New, J. Ammori, B.J. (2010)”Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass”Surg Obes Relat Dis Apr 7. 29.Israili,Z.H. (2009)”Advances in the treatment of type 2 diabetes mellitus”Am J Ther Oct.14-16. 30.Keating, C.L. Moodie, J.b. Peeters, A. O’Brien, J.Playfair P.E. (2009)”Cost –efficacy of surgically induced weight loss for the management of type 2 diabetes: a randomized control trial”Diabetes Care Vol.32 580-584. 31.Lin, T. Chou, P. Lai, M.S. Tsai, S.T. Tai, T.Y. (2001),”Direct cost–of–illness of patient with diabetes mellitus in Taiwan”Diabetes Research and Clinical Practice Vol.54. Suppl S43-S46. 32.Lin, T. Chou,P. Tsai,S.T. Lee,Y.C. Tai,T.Y. (2004)”Predicting factors associated with costs of diabetes patients in Taiwan” Diabetes Research and Clinical Practice Vol.63, 119-125. 33.Lee,T.T. Cheng, S.H. Chen, C.C. Lai, M.S. (2010)”pay-for-performance program for diabetes care in Taiwan: a preliminary assessment”Am J Manag Care Vol.16, 65-69. 34.Lee, W.J. Wang,W. Lee,Y.C. Huang,M.T. Ser,K.H. Chen,J.C. (2008) ”Effect of laparoscopy mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI>35 and BMI<35kg/m2, ”Journal of Gastrointestinal Surgery ,Vol.12, no.5, 945-952. 35.Lee,W.J. Chong,K. Lee,Y.C. Ser,K.H. Chen,J.C. Peng,W.P. Chen,C.M. (2009)”Effect of obesity surgery on type 2 diabetes mellitus Asian patients ,”World J Surg,Vol. 33,1895-1903. 36.Laville, M. Disse, E. (2009)”Bariatric surgery for diabetes treatement: Why should we go rapid to surgery”Diabetes & Metabolism Vol.35, 562-563. 37.Mumme, D.E. Mathiason, M.A. Kallies, K. J. Kothari, S.N. (2009)”Effect of Laparoscopic Roux-en-Y gastric bypass surgery on hemoglobin A1C levels in diabetic patients: a matched-cohort analysis,”Surg Obes Relat Dis Vol.5 (1), 4-10. 38.Muller, M. Nocito, K. Schiesser, A. M. (2010)”Surgery for diabetes type 2?”Praxic Vol.99 (4), 241-247. 39.Makary,M.A. Clarke,J.M. Shore,A.D. Magnuson,T.H. Richards,T. Bass,E.B. Dominici,F. Weiner,J.P. Wu, A.W. Segal,J.B. (2010)”Medication utilization and annual health care costs in patients with type 2 diabetes mellitus before and after baiatric surgery”Arch Surg Vol.245,726-731. 40.Nuboer,R. Borsboom, G.J. Zoethout,J.A. Koot,H.M. Bruining,J. (2008)”Effects of insulin pump vs. injection treatment on quality of life and impact of disease in children with type 1 diabetes mellitus in a randomized, prospective comparison”Pediatr Diabetes Vol.28, 291-296. 41.Nestor, V. Aurora, D.P. (2008)”Safty, effectiveness, and cost effectiveness of metabolic surgery in the treatment of type 2 diabetes mellitus,” Journal of Obesity, Vol.2011, 1-6. 42.Nicolas, V.C. John, S.S. Liberman, M. Stephane, A. Alexander, P.H. Lloyd, D. (2004)”Surgery decrease long-term mortality, morbidity, and health care use in morbidly obese patient,”Annals of Surgery Vol.240, 416-424. 43.Pscherer,S. Dietrich,E.S. Dippel,F.W. Neilson,A.R. (2010)”Comparison of one-year costs of type 2 diabetes treatment with insulin glargine or insulin detemir in a basal supported oral therapy in Germany”Int J Clin Pharmacol Ther Vol.48. 129-137 44.Pawaskar,M.D. Camacho,F.T. Anderson, R.T. Cobden,D. Joshi,A.V. Balkrishnan, R. (2007)”Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis”Clin Ther Vol.29 1294-1305 45.Rubino, F. (2006)”Bariatric surgery: effects on glucose homeostasis”Curr Opin Clin Nutr Metab Care Vol.9, 497-507. 46.Roglic, G. Unwin, N. Bennett, P.H. Mathers, C. (2005)”The burden of mortality attributable to diabetes”Diabetes Care Vol.28, 2130-2135. 47.Scheen, A.J. Flines, J.D. Roover, A.D. Paquot, N. (2009)”Bariatric surgery in patients with type 2 diabetes: benefits, risks, indications and perspectives”Diabetea & Metabolism Vol.35, 537-543. 48.Salameh,B.S. Khoukaz, M.T. Bell, R.L. (2010)”Metabolic and nutritional change after bariatric surgery”Gastroenterol. Hepatol.Vol.4, 217-223 49.Shaya,F.T. Yan, X. P. Lin,J. Donner, T.W. (2010)”US trends in glycemic control, treatment, and comorbidity burden in patients with diabetes”J Clin Hypertens Vol.12, 826-832. 50.Smushkin, G. Vella, A. (2010),”What is type 2 diabetes?”Medicine Vol.38, 597-601. 51.Salem, L. Devlin, A. Sullivan, S.D. Flum, D.R. (2008)”A cost –effectiveness analysis of laparoscopic gastric bypass, adjustable gastric banding and non-surgery weight loss interventions”Surg Obes Relat Dis Vol.4, 26-32. 52.Sandoz, M.S. Ess, S.M. Keusch,G.W. Schwenkglenks,M. Szucs,T.D. (2004) ”Prevalence and direct medical costs of end-stage renal disease in patient with type 2 diabetes mellitus in Switzerland for 2001”Swiss Med Wkly Vol.134, 448-458. 53.Sjostrom, L. Narbro, K. (2007)”Effects of bariatric surgery on mortality in Swedish obese subjects”The New England Journal of Medicine Vol.357, 741-752. 54.St Charles,M.E. Sadri,H. Minshall,M.E. Tunis,S.L. (2009)”Health economic comparison between continuous subcutaneous insulin infusion and multiple daily injections of insulin for the treatment of adult type 1 diabetes in Canada”Clin Ther Vol.31, 657-667. 55.Thomas, S. Schauer, P. (2010)”Bariatric surgery and the gut hormone response”Nutrition in Clinical Practice Vol.25, 175-183. 56.Tharkar, S. Devarajan, A. Kumptla, S. Viswanathan, V. (2010)”The socioeconomics of diabetes from a developing country: a population base cost of illness study”Diabetes Research Clinical Practice Vol.89, 334-340. 57.Talar, T. Candice, J. Erik, D. (2008)”Bariatric surgery and type 2 diabetes mellitus: Surgically induced remission” Journal of Diabetes Science and Technology Vol.2, 685-691. 58.Wei,J.N. Sung,F.C. Chou,C.W. Li,C.Y. Tsuang,M.S, Wang,P.J. Chou,C.W. Tung,J.N. Chuang,L.M. (2002)”Comparsion in diadetes-related complications for inpatients among university medical centers,regional hospitals and district hospitals”Taiwan J Public Health,Vol.21,115-122. 59.Wild, S. Roglic, G. A. Sicree, G.R. King, H. (2004),”Global prevalence of diabetes, Estimates for the year 2000 and projections for 2030”Diabetes Care Vol.27, 1047-1067. 60.World Health Organization (2009)”Diabetes Programme ” 61.World Health Organization(2009)”Definition and Diagnosis of Diabetes mellitus and intermediate hyperglycaemia”
|